{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T19:54:49Z","timestamp":1782158089106,"version":"3.54.5"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Science and Technology Research Project of Henan Province","award":["232102310389"],"award-info":[{"award-number":["232102310389"]}]},{"name":"the Key Scientific Research Project of Higher Education Institutions in Henan Province","award":["25A150012"],"award-info":[{"award-number":["25A150012"]}]},{"name":"the Key Scientific Research Project of Higher Education Institutions in Henan Province","award":["25B150017"],"award-info":[{"award-number":["25B150017"]}]},{"name":"Youth Project of Henan Provincial Natural Science Foundation","award":["No. 252300421731"],"award-info":[{"award-number":["No. 252300421731"]}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["242300421307"],"award-info":[{"award-number":["242300421307"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["21603180"],"award-info":[{"award-number":["21603180"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific and Technological Innovation Talents in the Colleges and Universities in Henan Province","award":["22HASTIT050"],"award-info":[{"award-number":["22HASTIT050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"DOI":"10.1186\/s13065-025-01575-2","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T07:41:06Z","timestamp":1751614866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Virtual screening, optimization design, and synthesis analysis of novel benzofuran derivatives as pan-genotypic HCV NS5B polymerase inhibitors using molecular modeling"],"prefix":"10.1186","volume":"19","author":[{"given":"Di","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongcheng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taigang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoli","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongya","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghe","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"issue":"3","key":"1575_CR1","doi-asserted-by":"publisher","first-page":"101626","DOI":"10.1016\/j.clinre.2021.101626","volume":"45","author":"S Roger","year":"2021","unstructured":"Roger S, Ducancelle A, Le Guillou-Guillemette H, Gaudy C, Lunel F. HCV virology and diagnosis. Clin Res Hepatol Gastroenterol. 2021;45(3):101626.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1575_CR2","doi-asserted-by":"publisher","first-page":"114595","DOI":"10.1016\/j.ejmech.2022.114595","volume":"240","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Zhang J, Zhou E, Ren C, Wang J, Wang Y. Small molecule NS5B RdRp non-nucleoside inhibitors for the treatment of HCV infection: A medicinal chemistry perspective. Eur J Med Chem. 2022;240:114595.","journal-title":"Eur J Med Chem"},{"issue":"10207","key":"1575_CR3","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","volume":"394","author":"CW Spearman","year":"2019","unstructured":"Spearman CW, Dusheiko GM, Hellard M, Sonderup M, Hepatitis C. Lancet. 2019;394(10207):1451\u201366.","journal-title":"Lancet"},{"key":"1575_CR4","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ejmech.2018.12.045","volume":"164","author":"NM Ganta","year":"2019","unstructured":"Ganta NM, Gedda G, Rathnakar B, Satyanarayana M, Yamajala B, Ahsan MJ, Jadav SS, Balaraju T. A review on HCV inhibitors: significance of non-structural polyproteins. Eur J Med Chem. 2019;164:576\u2013601.","journal-title":"Eur J Med Chem"},{"issue":"5","key":"1575_CR5","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/hep.31182","volume":"71","author":"P Roingeard","year":"2020","unstructured":"Roingeard P, Beaumont E. Hepatitis C vaccine: 10 good reasons for continuing. Hepatology. 2020;71(5):1845\u201350.","journal-title":"Hepatology"},{"key":"1575_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12985-015-0450-x","volume":"12","author":"K Kumthip","year":"2015","unstructured":"Kumthip K, Maneekarn N. The role of HCV proteins on treatment outcomes. Virol J. 2015;12:217.","journal-title":"Virol J"},{"issue":"2","key":"1575_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1128\/JCM.03042-12","volume":"51","author":"M Cruz-Rivera","year":"2013","unstructured":"Cruz-Rivera M, Carpio-Pedroza JC, Escobar-Gutierrez A, Lozano D, Vergara-Castaneda A, Rivera-Osorio P, Martinez-Guarneros A, Chacon CA, Fonseca-Coronado S, Vaughan G. Rapid hepatitis C virus divergence among chronically infected individuals. J Clin Microbiol. 2013;51(2):629\u201332.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"1575_CR8","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/nm.3351","volume":"19","author":"JR Honegger","year":"2013","unstructured":"Honegger JR, Kim S, Price AA, Kohout JA, McKnight KL, Prasad MR, Lemon SM, Grakoui A, Walker CM. Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses. Nat Med. 2013;19(11):1529\u201333.","journal-title":"Nat Med"},{"key":"1575_CR9","doi-asserted-by":"crossref","unstructured":"Martinez MA, Franco S. Therapy implications of hepatitis C virus genetic diversity. Viruses. 2020;13(1).","DOI":"10.3390\/v13010041"},{"issue":"3","key":"1575_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","volume":"2","author":"HCVC Polaris Observatory","year":"2017","unstructured":"Polaris Observatory HCVC. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2(3):161\u201376.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"11","key":"1575_CR11","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/infdis\/jiy401","volume":"218","author":"SM Borgia","year":"2018","unstructured":"Borgia SM, Hedskog C, Parhy B, Hyland RH, Stamm LM, Brainard DM, Subramanian MG, McHutchison JG, Mo H, Svarovskaia E, et al. Identification of a novel hepatitis C virus genotype from punjab, india: expanding classification of hepatitis C virus into 8 genotypes. J Infect Dis. 2018;218(11):1722\u20139.","journal-title":"J Infect Dis"},{"issue":"1","key":"1575_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/hep.26744","volume":"59","author":"DB Smith","year":"2014","unstructured":"Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, Simmonds P. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology. 2014;59(1):318\u201327.","journal-title":"Hepatology"},{"key":"1575_CR13","doi-asserted-by":"crossref","unstructured":"Alazard-Dany N, Denolly S, Boson B, Cosset FL. Overview of HCV life cycle with a special focus on current and possible future antiviral targets. Viruses. 2019;11(1).","DOI":"10.3390\/v11010030"},{"issue":"11","key":"1575_CR14","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.3390\/v14112570","volume":"14","author":"F Fabrizi","year":"2022","unstructured":"Fabrizi F, Tripodi F, Cerutti R, Nardelli L, Alfieri CM, Donato MF, Castellano G. Recent information on Pan-Genotypic Direct-Acting antiviral agents for HCV in chronic kidney disease. Viruses. 2022;14(11):2570.","journal-title":"Viruses"},{"key":"1575_CR15","doi-asserted-by":"publisher","first-page":"116699","DOI":"10.1016\/j.bmc.2022.116699","volume":"60","author":"J Su","year":"2022","unstructured":"Su J, Zhai Q, Wei D. Recent advancement in small molecules as HCV inhibitors. Bioorg Med Chem. 2022;60:116699.","journal-title":"Bioorg Med Chem"},{"issue":"5","key":"1575_CR16","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jhep.2018.07.002","volume":"69","author":"J Vermehren","year":"2018","unstructured":"Vermehren J, Park JS, Jacobson IM, Zeuzem S. Challenges and perspectives of direct antivirals for the treatment of hepatitis C virus infection. J Hepatol. 2018;69(5):1178\u201387.","journal-title":"J Hepatol"},{"issue":"4","key":"1575_CR17","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.3748\/wjg.v22.i4.1684","volume":"22","author":"M Umer","year":"2016","unstructured":"Umer M, Iqbal M. Hepatitis C virus prevalence and genotype distribution in pakistan: comprehensive review of recent data. World J Gastroenterol. 2016;22(4):1684\u2013700.","journal-title":"World J Gastroenterol"},{"key":"1575_CR18","doi-asserted-by":"crossref","unstructured":"Warkad SD, Nimse SB, Song KS, Kim T. HCV detection, discrimination, and genotyping technologies. Sens (Basel). 2018;18(10).","DOI":"10.3390\/s18103423"},{"issue":"19","key":"1575_CR19","doi-asserted-by":"publisher","first-page":"10794","DOI":"10.1021\/acsomega.0c00386","volume":"5","author":"SD Warkad","year":"2020","unstructured":"Warkad SD, Nimse SB, Song KS, Kim T. Development of a method for screening and genotyping of HCV 1a, 1b, 2, 3, 4, and 6 genotypes. ACS Omega. 2020;5(19):10794\u20139.","journal-title":"ACS Omega"},{"key":"1575_CR20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.meegid.2017.08.011","volume":"66","author":"JH Ellwanger","year":"2018","unstructured":"Ellwanger JH, Kaminski VL, Valverde-Villegas JM, Simon D, Lunge VR, Chies JAB. Immunogenetic studies of the hepatitis C virus infection in an era of pan-genotype antiviral therapies - Effective treatment is coming. Infect Genet Evol. 2018;66:376\u201391.","journal-title":"Infect Genet Evol"},{"issue":"1 Suppl","key":"1575_CR21","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1016\/j.jhep.2014.09.019","volume":"61","author":"N Ford","year":"2014","unstructured":"Ford N, Swan T, Beyer P, Hirnschall G, Easterbrook P, Wiktor S. Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settings. J Hepatol. 2014;61(1 Suppl):S132\u2013138.","journal-title":"J Hepatol"},{"issue":"4","key":"1575_CR22","first-page":"1427","volume":"11","author":"Y Song","year":"2022","unstructured":"Song Y, Li Y, Cheng H, Du X, Mi J, Le LV, Chen Z, Chan P, Sun J. Eliminate hepatitis C as a public health threat: A narrative review of strategies, gaps, and opportunities for China. Infect Dis Ther. 2022;11(4):1427\u201342.","journal-title":"Infect Dis Ther"},{"issue":"10","key":"1575_CR23","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.1021\/acs.jmedchem.0c00082","volume":"63","author":"B Liu","year":"2020","unstructured":"Liu B, Gai K, Qin H, Wang J, Liu X, Cao Y, Lu Q, Lu D, Chen D, Shen H, et al. Discovery of a Silicon-Containing Pan-Genotype hepatitis C virus NS5A inhibitor. J Med Chem. 2020;63(10):5312\u201323.","journal-title":"J Med Chem"},{"key":"1575_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1743-422X-8-161","volume":"8","author":"UAJT Ashfaq","year":"2011","unstructured":"Ashfaq UAJT, Rehman S, et al. An overview of HCV molecular biology, replication and immune responses. Virol J. 2011;8:161.","journal-title":"Virol J"},{"issue":"3","key":"1575_CR25","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1574-6976.2011.00319.x","volume":"36","author":"R Thimme","year":"2012","unstructured":"Thimme R, Binder M, Bartenschlager R. Failure of innate and adaptive immune responses in controlling hepatitis C virus infection. FEMS Microbiol Rev. 2012;36(3):663\u201383.","journal-title":"FEMS Microbiol Rev"},{"key":"1575_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.antiviral.2014.01.006","volume":"104","author":"W Xue","year":"2014","unstructured":"Xue W, Jiao P, Liu H, Yao X. Molecular modeling and residue interaction network studies on the mechanism of binding and resistance of the HCV NS5B polymerase mutants to VX-222 and ANA598. Antiviral Res. 2014;104:40\u201351.","journal-title":"Antiviral Res"},{"issue":"4","key":"1575_CR27","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1128\/JVI.74.4.2046-2051.2000","volume":"74","author":"AAMK Kolykhalov","year":"2000","unstructured":"Kolykhalov AAMK, Feinstone SM, Rice CM. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3\u2019 nontranslated region are essential for virus replication in vivo. J Virol. 2000;74(4):2046\u201351.","journal-title":"J Virol"},{"issue":"2","key":"1575_CR28","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1006\/bbrc.1995.2526","volume":"215","author":"TKN Tanaka","year":"1995","unstructured":"Tanaka TKN, Cho MJ, Shimotohno K. A novel sequence found at the 3\u2019 terminus of hepatitis C virus genome. Biochem Biophys Res Commun. 1995;215(2):744\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1575_CR29","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1128\/jvi.66.3.1476-1483.1992","volume":"66","author":"KIN Tsukiyama-Kohara","year":"1992","unstructured":"Tsukiyama-Kohara KIN, Kohara M, et al. Internal ribosome entry site within hepatitis C virus RNA. J Virol. 1992;66(3):1476\u201383.","journal-title":"J Virol"},{"issue":"6","key":"1575_CR30","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1128\/jvi.67.6.3338-3344.1993","volume":"67","author":"CSP Wang","year":"1993","unstructured":"Wang CSP, Siddiqui A. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J Virol. 1993;67(6):3338\u201344.","journal-title":"J Virol"},{"issue":"2","key":"1575_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1006\/bbrc.1993.1429","volume":"192","author":"MRSM Eckart","year":"1993","unstructured":"Eckart MRSM, Masiarz F, Lee C, Berger K, Crawford K, Kuo C, Kuo G, Houghton M, Choo QL. The hepatitis C virus encodes a Serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor. Biochem Biophys Res Commun. 1993;192(2):399\u2013406.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1575_CR32","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/v13050833","volume":"13","author":"I Yechezkel","year":"2021","unstructured":"Yechezkel I, Law M, Tzarum N. From structural studies to HCV vaccine design. Viruses. 2021;13(5):833.","journal-title":"Viruses"},{"issue":"32","key":"1575_CR33","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.2174\/092986710793205471","volume":"17","author":"RRCJ Deore","year":"2010","unstructured":"Deore RRCJ. NS5B RNA dependent RNA polymerase inhibitors: the promising approach to treat hepatitis C virus infections. Curr Med Chem. 2010;17(32):3806\u201326.","journal-title":"Curr Med Chem"},{"issue":"4","key":"1575_CR34","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jhep.2020.06.029","volume":"73","author":"JM Pawlotsky","year":"2020","unstructured":"Pawlotsky JM. About the absolute need to keep active research on the efficacy of direct-acting antiviral drugs against the hepatitis C virus. J Hepatol. 2020;73(4):752\u20134.","journal-title":"J Hepatol"},{"issue":"7","key":"1575_CR35","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nrmicro3046","volume":"11","author":"R Bartenschlager","year":"2013","unstructured":"Bartenschlager R, Lohmann V, Penin F. The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection. Nat Rev Microbiol. 2013;11(7):482\u201396.","journal-title":"Nat Rev Microbiol"},{"issue":"20","key":"1575_CR36","doi-asserted-by":"publisher","first-page":"14399","DOI":"10.1074\/jbc.M113.529743","volume":"289","author":"P Karam","year":"2014","unstructured":"Karam P, Powdrill MH, Liu HW, Vasquez C, Mah W, Bernatchez J, Gotte M, Cosa G. Dynamics of hepatitis C virus (HCV) RNA-dependent RNA polymerase NS5B in complex with RNA. J Biol Chem. 2014;289(20):14399\u2013411.","journal-title":"J Biol Chem"},{"key":"1575_CR37","doi-asserted-by":"publisher","first-page":"104371","DOI":"10.1016\/j.meegid.2020.104371","volume":"84","author":"H Khalid","year":"2020","unstructured":"Khalid H, Landry KB, Ijaz B, Ashfaq UA, Ahmed M, Kanwal A, Froeyen M, Mirza MU. Discovery of novel hepatitis C virus inhibitor targeting multiple allosteric sites of NS5B polymerase. Infect Genet Evol. 2020;84:104371.","journal-title":"Infect Genet Evol"},{"issue":"10","key":"1575_CR38","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s10822-021-00418-1","volume":"35","author":"AA Malik","year":"2021","unstructured":"Malik AA, Chotpatiwetchkul W, Phanus-Umporn C, Nantasenamat C, Charoenkwan P, Shoombuatong W. StackHCV: a web-based integrative machine-learning framework for large-scale identification of hepatitis C virus NS5B inhibitors. J Comput Aided Mol Des. 2021;35(10):1037\u201353.","journal-title":"J Comput Aided Mol Des"},{"issue":"5","key":"1575_CR39","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1080\/07391102.2019.1608864","volume":"38","author":"P Polamreddy","year":"2020","unstructured":"Polamreddy P, Vishwakarma V, Arumugam P, Bheemanati R, Esram P, Mahto MK, Kacker P. Discovery of hit molecules targeting allosteric site of hepatitis C virus NS5B polymerase. J Biomol Struct Dyn. 2020;38(5):1448\u201366.","journal-title":"J Biomol Struct Dyn"},{"key":"1575_CR40","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ejmech.2012.09.010","volume":"58","author":"AG Golub","year":"2012","unstructured":"Golub AG, Gurukumar KR, Basu A, Bdzhola VG, Bilokin Y, Yarmoluk SM, Lee JC, Talele TT, Nichols DB, Kaushik-Basu N. Discovery of new scaffolds for rational design of HCV NS5B polymerase inhibitors. Eur J Med Chem. 2012;58:258\u201364.","journal-title":"Eur J Med Chem"},{"key":"1575_CR41","doi-asserted-by":"crossref","unstructured":"McComas CC, Palani A, Chang W, Holloway MK, Lesburg CA, Li P, Liverton N, Meinke PT, Olsen DB, Peng X et al. Development of a New Structural Class of Broadly Acting HCV Non-Nucleoside Inhibitors Leading to the Discovery of MK-8876. ChemMedChem 2017, 12(17):1436\u20131448.","DOI":"10.1002\/cmdc.201700228"},{"issue":"8","key":"1575_CR42","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.4155\/fmc.11.53","volume":"3","author":"MLIN Barreca","year":"2011","unstructured":"Barreca MLIN, Manfroni G, Cecchetti V. Allosteric Inhibition of the hepatitis C virus NS5B polymerase: in Silico strategies for drug discovery and development. Future Med Chem. 2011;3(8):1027\u201355.","journal-title":"Future Med Chem"},{"issue":"15","key":"1575_CR43","doi-asserted-by":"publisher","first-page":"8028","DOI":"10.3390\/ijms25158028","volume":"25","author":"D Han","year":"2024","unstructured":"Han D, Zhao F, Chen Y, Xue Y, Bao K, Chang Y, Lu J, Wang M, Liu T, Gao Q. Distinct characteristic binding modes of Benzofuran core inhibitors to diverse genotypes of hepatitis C virus NS5B polymerase: A molecular simulation study. Int J Mol Sci. 2024;25(15):8028.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1575_CR44","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/ci3001277","volume":"52","author":"JJ Irwin","year":"2012","unstructured":"Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG. ZINC: a free tool to discover chemistry for biology. J Chem Inf Model. 2012;52(7):1757\u201368.","journal-title":"J Chem Inf Model"},{"key":"1575_CR45","doi-asserted-by":"publisher","first-page":"113705","DOI":"10.1016\/j.ejmech.2021.113705","volume":"224","author":"VT Sabe","year":"2021","unstructured":"Sabe VT, Ntombela T, Jhamba LA, Maguire GEM, Govender T, Naicker T, Kruger HG. Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review. Eur J Med Chem. 2021;224:113705.","journal-title":"Eur J Med Chem"},{"issue":"11","key":"1575_CR46","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling T, Irwin JJ. ZINC 15\u2013Ligand discovery for everyone. J Chem Inf Model. 2015;55(11):2324\u201337.","journal-title":"J Chem Inf Model"},{"issue":"12","key":"1575_CR47","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1021\/acs.jcim.9b01210","volume":"60","author":"M Grimm","year":"2020","unstructured":"Grimm M, Liu Y, Yang X, Bu C, Xiao Z, Cao Y. LigMate: A multifeature integration algorithm for Ligand-Similarity-Based virtual screening. J Chem Inf Model. 2020;60(12):6044\u201353.","journal-title":"J Chem Inf Model"},{"issue":"1","key":"1575_CR48","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep.27259","volume":"61","author":"JP Messina","year":"2015","unstructured":"Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61(1):77\u201387.","journal-title":"Hepatology"},{"issue":"5","key":"1575_CR49","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1021\/jm400317w","volume":"57","author":"A Maynard","year":"2014","unstructured":"Maynard A, Crosby RM, Ellis B, Hamatake R, Hong Z, Johns BA, Kahler KM, Koble C, Leivers A, Leivers MR, et al. Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymerase. J Med Chem. 2014;57(5):1902\u201313.","journal-title":"J Med Chem"},{"issue":"4","key":"1575_CR50","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1039\/C6MD00636A","volume":"8","author":"KJ Eastman","year":"2017","unstructured":"Eastman KJ, Parcella K, Yeung KS, Grant-Young KA, Zhu J, Wang T, Zhang Z, Yin Z, Beno BR, Sheriff S, et al. The discovery of a pan-genotypic, primer grip inhibitor of HCV NS5B polymerase. Medchemcomm. 2017;8(4):796\u2013806.","journal-title":"Medchemcomm"},{"issue":"16","key":"1575_CR51","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1021\/jm900517t","volume":"52","author":"JM Ontoria","year":"2009","unstructured":"Ontoria JM, Rydberg EH, Di Marco S, Tomei L, Attenni B, Malancona S, Martin Hernando JI, Gennari N, Koch U, Narjes F, et al. Identification and biological evaluation of a series of 1H-benzo[de]isoquinoline-1,3(2H)-diones as hepatitis C virus NS5B polymerase inhibitors. J Med Chem. 2009;52(16):5217\u201327.","journal-title":"J Med Chem"},{"issue":"8","key":"1575_CR52","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1021\/acs.jcim.9b00977","volume":"28","author":"WLSC Ye","year":"2020","unstructured":"Ye WLSC, Xiong GL, Ding JJ, Lu AP, Hou TJ, Cao DS. Improving Docking-Based virtual screening ability by integrating multiple energy auxiliary terms from molecular Docking scoring. J Chem Inf Model. 2020;28(8):4216\u201330.","journal-title":"J Chem Inf Model"},{"issue":"6","key":"1575_CR53","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s10822-012-9570-1","volume":"26","author":"CR Corbeil","year":"2012","unstructured":"Corbeil CR, Williams CI, Labute P. Variability in Docking success rates due to dataset Preparation. J Comput Aided Mol Des. 2012;26(6):775\u201386.","journal-title":"J Comput Aided Mol Des"},{"key":"1575_CR54","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-1-4939-7756-7_9","volume":"1762","author":"G Menchon","year":"2018","unstructured":"Menchon G, Maveyraud L, Czaplicki G. Molecular dynamics as a tool for virtual ligand screening. Methods Mol Biol. 2018;1762:145\u201378.","journal-title":"Methods Mol Biol"},{"issue":"18","key":"1575_CR55","doi-asserted-by":"publisher","first-page":"5882","DOI":"10.1021\/acs.jpcb.5b00689","volume":"119","author":"KG Sprenger","year":"2015","unstructured":"Sprenger KG, Jaeger VW, Pfaendtner J. The general AMBER force field (GAFF) can accurately predict thermodynamic and transport properties of many ionic liquids. J Phys Chem B. 2015;119(18):5882\u201395.","journal-title":"J Phys Chem B"},{"issue":"8","key":"1575_CR56","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput. 2015;11(8):3696\u2013713.","journal-title":"J Chem Theory Comput"},{"issue":"23","key":"1575_CR57","doi-asserted-by":"publisher","first-page":"231101","DOI":"10.1063\/1.3671638","volume":"135","author":"SR Kimura","year":"2011","unstructured":"Kimura SR, Rajamani R, Langley DR. Communication: quantum polarized fluctuating charge model: a practical method to include ligand polarizability in biomolecular simulations. J Chem Phys. 2011;135(23):231101.","journal-title":"J Chem Phys"},{"issue":"2","key":"1575_CR58","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","volume":"25","author":"J Wang","year":"2006","unstructured":"Wang J, Wang W, Kollman PA, Case DA. Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model. 2006;25(2):247\u201360.","journal-title":"J Mol Graph Model"},{"issue":"7","key":"1575_CR59","doi-asserted-by":"publisher","first-page":"074504","DOI":"10.1063\/1.5017694","volume":"148","author":"S Mamatkulov","year":"2018","unstructured":"Mamatkulov S, Schwierz N. Force fields for monovalent and divalent metal cations in TIP3P water based on thermodynamic and kinetic properties. J Chem Phys. 2018;148(7):074504.","journal-title":"J Chem Phys"},{"issue":"12","key":"1575_CR60","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/ar000033j","volume":"33","author":"PAMI Kollman","year":"2000","unstructured":"Kollman PAMI, Reyes C, Kuhn B, Huo S, Chong L, Lee M, Lee T, Duan Y, Wang W, Donini O, Cieplak P, Srinivasan J, Case DA. Cheatham TE 3rd: calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res. 2000;33(12):889\u201397.","journal-title":"Acc Chem Res"},{"key":"1575_CR61","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","volume":"64","author":"CA Lipinski","year":"2012","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2012;64:4\u201317.","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"1575_CR62","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45(12):2615\u201323.","journal-title":"J Med Chem"},{"issue":"8","key":"1575_CR63","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3390\/pharmaceutics11080411","volume":"11","author":"D Dahlgren","year":"2019","unstructured":"Dahlgren D, Lennern\u00e4s H. Intestinal permeability and drug absorption: predictive experimental, computational and in vivo approaches. Pharmaceutics. 2019;11(8):411.","journal-title":"Pharmaceutics"},{"issue":"W1","key":"1575_CR64","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, Yin M, Zeng X, Wu C, Lu A, et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 2021;49(W1):W5\u201314.","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"1575_CR65","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1002\/anie.201506101","volume":"55","author":"S Szymku\u0107","year":"2016","unstructured":"Szymku\u0107 S, Gajewska EP, Klucznik T, Molga K, Dittwald P, Startek M, Bajczyk M, Grzybowski BA. Computer-assisted synthetic planning: the end of the beginning. Angew Chem Int Ed. 2016;55(20):5904\u201337.","journal-title":"Angew Chem Int Ed"},{"key":"1575_CR66","doi-asserted-by":"crossref","unstructured":"Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1).","DOI":"10.1038\/srep42717"},{"issue":"2","key":"1575_CR67","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1517\/17460441.2012.648612","volume":"7","author":"WP Walters","year":"2012","unstructured":"Walters WP. Going further than lipinski\u2019s rule in drug design. Expert Opin Drug Discov. 2012;7(2):99\u2013107.","journal-title":"Expert Opin Drug Discov"},{"issue":"9","key":"1575_CR68","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1021\/jm0492002","volume":"48","author":"YC Martin","year":"2005","unstructured":"Martin YC. A bioavailability score. J Med Chem. 2005;48(9):3164\u201370.","journal-title":"J Med Chem"},{"issue":"4","key":"1575_CR69","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1021\/ci400001u","volume":"53","author":"VK Gombar","year":"2013","unstructured":"Gombar VK, Hall SD. Quantitative structure-activity relationship models of clinical pharmacokinetics: clearance and volume of distribution. J Chem Inf Model. 2013;53(4):948\u201357.","journal-title":"J Chem Inf Model"},{"issue":"1","key":"1575_CR70","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12918-017-0486-1","volume":"11","author":"JY Wang","year":"2017","unstructured":"Wang JY, Chen H, Wang YY, Wang XQ, Chen HY, Zhang M, Tang Y, Zhang B. Network Pharmacological mechanisms of Vernonia anthelmintica (L.) in the treatment of vitiligo: Isorhamnetin induction of melanogenesis via up-regulation of melanin-biosynthetic genes. BMC Syst Biol. 2017;11(1):103.","journal-title":"BMC Syst Biol"},{"issue":"2","key":"1575_CR71","doi-asserted-by":"publisher","first-page":"188355","DOI":"10.1016\/j.bbcan.2020.188355","volume":"1873","author":"S He","year":"2020","unstructured":"He S, Moutaoufik MT, Islam S, Persad A, Wu A, Aly KA, Fonge H, Babu M, Cayabyab FS. HERG channel and cancer: A mechanistic review of carcinogenic processes and therapeutic potential. Biochim Biophys Acta Rev Cancer. 2020;1873(2):188355.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"7","key":"1575_CR72","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.bpj.2015.03.005","volume":"108","author":"BC Davis","year":"2015","unstructured":"Davis BC, Brown JA, Thorpe IF. Allosteric inhibitors have distinct effects, but also common modes of action, in the HCV polymerase. Biophys J. 2015;108(7):1785\u201395.","journal-title":"Biophys J"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01575-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-025-01575-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01575-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T09:03:26Z","timestamp":1751619806000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-025-01575-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1575"],"URL":"https:\/\/doi.org\/10.1186\/s13065-025-01575-2","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"199"}}